Palm Beach Gardens Medical Center Offers Minimally Invasive Treatment Option for Heart Valve Patients

March 6, 2021

Palm Beach Gardens Medical Center is now offering patients new treatmentfor valve repair and replacement procedures.  

Palm Beach Gardens Medical Center is now able to perform minimally invasive surgery for several heart valve diseases.  Dr. Nishant Patel, cardiothoracic surgeon, is one of the first, and currently the only surgeon performing this procedure at the hospital.  

“These procedures are a breakthrough in our community, and we are looking forward to providing this level of care to our patients at Palm Beach Gardens Medical Center,” said Dr. Patel.  “Unlike traditional open heart surgery where the breast bone needs to be surgically separated, minimally invasive valve surgery is performed through a small incision between the ribs, which may offer less pain, scarring, and a faster return to your daily activities.

The following minimally procedures are now being offered at Palm Beach Gardens Medical Center:

Mitral Valve Repair and Replacement
Tricuspid Repair and Replacement
Aortic Valve Replacement
Ablation for Atrial Fibrillation
Atrial Septal Defect (ASD) Repair
Patent Foramen Ovale (PFO) Repair

“As one of the top heart hospitals in Palm Beach County, this is just another way we are able to bring some of the best cardiac care right here in our community,” said Teresa Urquhart, chief executive officer of Palm Beach Gardens Medical Center.“These new minimally invasive valve procedures will give people an easier recovery while being able to get back to their regular activities even quicker than before.  Our hospital has also taken the proper steps to continue providing safe and appropriate care to our patients.”  

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”